Dr. Kleopas Kleopa, MD, PhD, FAAN, FEAN
Dr. Kleopa is a clinician-scientist with extensive expertise in neurological and neuromuscular disorders, neuroscience, and gene therapy. His translational research has made significant contributions to the understanding of neurological disease mechanisms, focusing on neurogenetic, neuroinflammatory, and neuromuscular disorders and to the development of innovative cell-targeted gene therapies for inherited neuropathies and leukodystrophies, with results currently being developed for clinical translation in collaboration with industry.
His work has been published in more than 130 peer-reviewed high-impact scientific papers and has been recognized by numerous prestigious Awards, including the European Academy of Neurology Investigator Award and the Cyprus National Distinguished Researcher Award. He serves as Board Member of the Peripheral Nerve Society and as Vice-Chair of the Charcot-Marie-Tooth and Related Disorders Consortium (CMTR), and in Scientific Advisory Boards of Patient Associations, including the American CMT Association, the Gilbert Foundation Neurofibromatosis-1 Gene Therapy Initiative, and the PMD Foundation. He also co-chairs the Working Groups on Gene Therapies, Neuropathies, and Leukodystrophies of the European Reference Networks for rare neuromuscular and rare neurological disorders. Dr. Kleopa is currently working on developing a gene therapy for Pelizaeus-Merzbacher-like disease 1 (PMLD1).
Experience & Achievements:
Senior Consultant Neurologist
Head of Neuroscience Department
Professor, CING Postgraduate School
Head of Neuropathology Lab
Coordinator, Neuroscience Graduate Program
Coordinator, Center for Neuromuscular Disorders
Center for Multiple Sclerosis and Related Disorders